Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00533832 · ClinicalTrials.gov registry record · NA
Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)
A NA study, sponsored by Cyberonics.
- Completed
- Registry status
- NA
- Development phase
- 266
- Enrollment target
NCT00533832 is a NA study that has completed, run by Cyberonics. The registered enrollment target is 266 participants.
The verdict
NCT00533832, a NA study, has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
Study Summary
To confirm the safety and efficacy of the NCP System in treating patients in a nmajor depressive episode.
Interventions
- DEVICE vagus nerve stimulation (VNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2000-07 |
| Est. Completion | 2005-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00533832
The ClinicalTrials.gov registry entry for NCT00533832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cyberonics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vagus nerve stimulation (VNS) is the first listed.
NCT00533832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00533832 about?
NCT00533832 is a clinical study titled "Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)". To confirm the safety and efficacy of the NCP System in treating patients in a nmajor depressive episode.
What is the current status of trial NCT00533832?
This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2000-07. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00533832?
The interventions under investigation include: vagus nerve stimulation (VNS) (DEVICE).
Who is sponsoring clinical trial NCT00533832?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.